This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Feb;59(2):433-436.

doi: 10.1111/trf.15082.

Progress in US hemovigilance: can we still learn from others?

Barbee I Whitaker¹, Artur Belov¹, Steven A Anderson¹

Affiliations

PMID: 30727043
DOI: 10.1111/trf.15082

Editorial

Progress in US hemovigilance: can we still learn from others?

Barbee I Whitaker et al. Transfusion. 2019 Feb.

. 2019 Feb;59(2):433-436.

doi: 10.1111/trf.15082.

Authors

Barbee I Whitaker¹, Artur Belov¹, Steven A Anderson¹

Affiliation

¹ Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD.

PMID: 30727043
DOI: 10.1111/trf.15082

No abstract available

PubMed Disclaimer

Comment on

Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.
Edens C, Haass KA, Cumming M, Osinski A, O'Hearn L, Passanisi K, Eaton L, Visintainer P, Savinkina A, Kuehnert MJ, Basavaraju SV, Andrzejewski C. Edens C, et al. Transfusion. 2019 Feb;59(2):524-533. doi: 10.1111/trf.15008. Epub 2018 Nov 14. Transfusion. 2019. PMID: 30427540 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information